Pharmaceutical innovations and obligations under TRIPS

By Snodin M.

The author
  • Mike Snodin is the founder and director of Park Grove IP, a UK-based patent attorney firm that provides advice to companies in the chemical, pharmaceutical and life sciences fields. The views expressed in this article are the personal views of the author.
This article